As of May 30, 2025
iShares Biotechnology ETF (NASDAQ: IBB)
Ticker | Name | Share % | |
---|---|---|---|
GILD | Gilead Sciences Inc | 8.77% | |
REGN | Regeneron | 6.12% | |
VRTX | Nvaesrtex Pharmaceuticals Inc | 8.39% | |
AMGN | Amgen Inc. | 8.52% | |
IQV | I Q V I A Holdings Inc. | 2.90% | |
MRNA | Moderna therapeutics | 3.75% | |
MTD | Mettler-Toledo International Inc. | 2.82% | |
BIIB | Biogen Inc. Com | 2.22% | |
ALNY | Alnylam Pharmace | 4.47% | |
AS | Argenx Se Ads | 2.86% | |
WAT | Waters Corp. | 2.45% | |
FF | Biontech Se | 2.06% | |
NTRA | Natera Inc | 2.39% |
The IBB ETF is currently trading at $126.96, which represents a 1.52% change. Over the past 52 weeks, the ETF has traded as high as $150.57 and as low as $107.43.
The expense ratio of IBB is 0.45%. This represents the annual fee that all funds or ETFs charge their shareholders.
The total Assets Under Management (AUM) for IBB is 5.16B. This represents the total market value of the assets managed by the ETF.
IBB follows a Mid Cap Growth investment style.
The top holdings of IBB include: GILD (8.77%), REGN (6.12%), VRTX (8.39%), AMGN (8.52%), IQV (2.9%). These represent the largest positions in the ETF's portfolio.
Average daily volume data for IBB is currently not available.